{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T22:35:04Z","timestamp":1768257304813,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.vph.2023.107196","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T11:59:34Z","timestamp":1689595174000},"page":"107196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Sacubitril\/valsartan effects on arrhythmias and left ventricular remodelling in heart failure: An observational study"],"prefix":"10.1016","volume":"152","author":[{"given":"Mauro","family":"Acquaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Scelsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Pasotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Seganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Spolverini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Greco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Schirinzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Turco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Sanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Savastano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Rordorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Ghio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vph.2023.107196_bb0005","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1002\/ehf2.12918","article-title":"Sacubitrilat reduces pro-arrhythmogenic sarcoplasmic reticulum Ca2+ leak in human ventricular cardiomyocytes of patients with end-stage heart failure","volume":"7","author":"Eiringhaus","year":"2020","journal-title":"ESC Heart Fail."},{"issue":"6","key":"10.1016\/j.vph.2023.107196_bb0010","article-title":"Antiarrhythmic effect of sacubitril-valsartan: cause or consequence of clinical improvement?","volume":"8","author":"Gon\u00e7alves","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.vph.2023.107196_bb0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pbiomolbio.2020.02.008","article-title":"Cardiomyocyte calcium handling in health and disease: insights from in vitro and in silico studies","volume":"157","author":"Sutanto","year":"2020","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"2","key":"10.1016\/j.vph.2023.107196_bb0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/cvr\/cvp001","article-title":"Protein kinase C in heart failure: a therapeutic target?","volume":"82","author":"Palaniyandi","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.vph.2023.107196_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2012.08.005","article-title":"Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes","volume":"161","author":"Giudicessi","year":"2013","journal-title":"Transl. Res."},{"issue":"17","key":"10.1016\/j.vph.2023.107196_bb0030","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1161\/CIRCULATIONAHA.118.035455","article-title":"Modernized classification of cardiac antiarrhythmic drugs","volume":"138","author":"Lei","year":"2018","journal-title":"Circulation."},{"issue":"16","key":"10.1016\/j.vph.2023.107196_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168994","article-title":"Angiotensin receptor-neprilysin inhibitor (ARNI) and cardiac arrhythmias","volume":"22","author":"Sutanto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.vph.2023.107196_bb0040","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1007\/s00392-019-01440-y","article-title":"Sacubitril\/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction","volume":"108","author":"Martens","year":"2019","journal-title":"Clin. Res. Cardiol."},{"issue":"3","key":"10.1016\/j.vph.2023.107196_bb0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.hrthm.2017.11.012","article-title":"Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices","volume":"15","author":"de Diego","year":"2018","journal-title":"Heart Rhythm."},{"issue":"10","key":"10.1016\/j.vph.2023.107196_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm8101582","article-title":"Impact of sacubitril\/valsartan on the long-term incidence of ventricular arrhythmias in chronic heart failure patients","volume":"8","author":"El-Battrawy","year":"2019","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.vph.2023.107196_bb0055","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00380-019-01454-6","article-title":"Clinical characteristics of patients with sustained ventricular arrhythmias after sacubitril\/valsartan initiation","volume":"35","author":"Vicent","year":"2020","journal-title":"Heart Vessel."},{"issue":"3","key":"10.1016\/j.vph.2023.107196_bb0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ejhf.2419","article-title":"Effect of sacubitril\/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF","volume":"24","author":"Curtain","year":"2022","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"10.1016\/j.vph.2023.107196_bb0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/eurheartj\/eht451","article-title":"Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT","volume":"35","author":"Sood","year":"2014","journal-title":"Eur. Heart J."},{"issue":"18","key":"10.1016\/j.vph.2023.107196_bb0070","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2013.04.083","article-title":"Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked: the altitude survival by rhythm study","volume":"62","author":"Powell","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.vph.2023.107196_bb0075","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure","volume":"359","author":"Poole","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"Supplement_2","key":"10.1016\/j.vph.2023.107196_bb0080","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/ehjci\/ehaa946.0926","article-title":"Sacubitril\/valsartan reduces atrial fibrillation and supraventricular arrhythmias in patients with HFrEF and remote monitoring: preliminary data from the save the rhythm","volume":"41","author":"Guerra","year":"2020","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.vph.2023.107196_bb0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.14740\/jocmr4076","article-title":"Favorable effects of Sacubitril\/valsartan on the peak atrial longitudinal strain in patients with chronic heart failure and a history of one or more episodes of atrial fibrillation: a retrospective cohort study","volume":"12","author":"de Vecchis","year":"2020","journal-title":"J. Clin. Med. Res."},{"issue":"4","key":"10.1016\/j.vph.2023.107196_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1755-5922.12435","article-title":"The reverse remodeling response to sacubitril\/valsartan therapy in heart failure with reduced ejection fraction","volume":"36","author":"Martens","year":"2018","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.vph.2023.107196_bb0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2022.01.004","article-title":"Benefit from sacubitril\/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: an echocardiographic study","volume":"350","author":"Carluccio","year":"2022","journal-title":"Int. J. Cardiol."},{"issue":"12","key":"10.1016\/j.vph.2023.107196_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm8122165","article-title":"The effects of sacubitril\/valsartan on clinical, biochemical and echocardiographic parameters in patients with heart failure with reduced ejection fraction: The \u201chemodynamic recovery\u201d","volume":"8","author":"Romano","year":"2019","journal-title":"J. Clin. Med."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123000563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123000563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:24:26Z","timestamp":1761528266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189123000563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":20,"alternative-id":["S1537189123000563"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2023.107196","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sacubitril\/valsartan effects on arrhythmias and left ventricular remodelling in heart failure: An observational study","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2023.107196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107196"}}